Zacks Research Issues Positive Forecast for Palomar Earnings

Palomar Holdings, Inc. (NASDAQ:PLMR) – Research analysts at Zacks Research increased their Q2 2026 earnings per share estimates for shares of Palomar in a note issued to investors on Thursday, June 25th. Zacks Research analyst Team now expects that the company will earn $1.62 per share for the quarter, up from their previous estimate of $1.59. Zacks Research currently has a “Hold” rating on the stock. The consensus estimate for Palomar’s current full-year earnings is $9.14 per share.

Several other analysts have also commented on PLMR. Keefe, Bruyette & Woods decreased their price objective on Palomar from $186.00 to $159.00 and set an “outperform” rating for the company in a report on Wednesday, May 13th. Piper Sandler lowered their price target on shares of Palomar from $151.00 to $132.00 and set an “overweight” rating on the stock in a report on Monday, May 11th. Weiss Ratings upgraded shares of Palomar from a “hold (c)” rating to a “hold (c+)” rating in a research note on Thursday, June 18th. JPMorgan Chase & Co. lowered their price target on Palomar from $160.00 to $150.00 and set an “overweight” rating on the stock in a research report on Tuesday, May 26th. Finally, Wall Street Zen cut shares of Palomar from a “buy” rating to a “hold” rating in a research note on Sunday, March 1st. Four analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, Palomar has an average rating of “Moderate Buy” and an average price target of $147.75.

Palomar Trading Down 0.9%

NASDAQ PLMR opened at $117.84 on Friday. The company has a market capitalization of $3.12 billion, a price-to-earnings ratio of 16.41 and a beta of 0.44. Palomar has a one year low of $100.81 and a one year high of $156.55. The company has a debt-to-equity ratio of 0.31, a quick ratio of 0.49 and a current ratio of 0.49. The company’s 50-day simple moving average is $115.53 and its two-hundred day simple moving average is $122.37.

Palomar (NASDAQ:PLMR) last released its quarterly earnings data on Wednesday, May 6th. The company reported $2.31 earnings per share for the quarter, beating the consensus estimate of $2.17 by $0.14. Palomar had a return on equity of 22.62% and a net margin of 20.11%.The firm had revenue of $278.94 million during the quarter, compared to the consensus estimate of $557.79 million. During the same period in the previous year, the company posted $1.87 earnings per share. The firm’s quarterly revenue was up 59.7% on a year-over-year basis.

Insider Activity

In other news, CEO Mac Armstrong sold 3,500 shares of Palomar stock in a transaction on Monday, June 22nd. The stock was sold at an average price of $112.96, for a total value of $395,360.00. Following the completion of the sale, the chief executive officer directly owned 329,388 shares of the company’s stock, valued at approximately $37,207,668.48. The trade was a 1.05% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, President Jon Christianson sold 3,000 shares of the stock in a transaction dated Tuesday, April 7th. The stock was sold at an average price of $125.00, for a total value of $375,000.00. Following the transaction, the president directly owned 62,919 shares in the company, valued at approximately $7,864,875. The trade was a 4.55% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 18,634 shares of company stock valued at $2,291,441. 3.70% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the business. Geneos Wealth Management Inc. acquired a new stake in Palomar during the 4th quarter worth approximately $32,000. Kestra Advisory Services LLC purchased a new stake in shares of Palomar during the fourth quarter worth $33,000. Rockefeller Capital Management L.P. raised its stake in shares of Palomar by 81.5% in the fourth quarter. Rockefeller Capital Management L.P. now owns 294 shares of the company’s stock valued at $40,000 after acquiring an additional 132 shares in the last quarter. Clearstead Advisors LLC boosted its holdings in Palomar by 31.0% in the third quarter. Clearstead Advisors LLC now owns 397 shares of the company’s stock valued at $46,000 after purchasing an additional 94 shares during the period. Finally, Frazier Financial Advisors LLC acquired a new position in Palomar during the 4th quarter worth $54,000. Institutional investors and hedge funds own 90.25% of the company’s stock.

Key Stories Impacting Palomar

Here are the key news stories impacting Palomar this week:

• Positive Sentiment: Zacks Research raised its FY2026 earnings estimate for Palomar to $9.87 per share from $8.99, which suggests stronger profit expectations for the next fiscal year. Palomar Holdings analyst update
• Positive Sentiment: The company was highlighted as a property & casualty insurer that may be better positioned to handle the 2026 hurricane season, supporting the bullish case for its specialty insurance model. Article about P&C insurers poised to weather hurricane season
• Neutral Sentiment: Zacks Research maintained a Hold rating, which signals analysts see limited near-term upside even though some earnings estimates improved. Palomar Holdings analyst rating
• Neutral Sentiment: CEO Mac Armstrong sold 3,500 shares in a pre-arranged Rule 10b5-1 transaction, which is a routine insider sale but can still weigh on sentiment. SEC insider filing
• Negative Sentiment: Zacks trimmed some future earnings forecasts, including Q3 2026 and FY2027, which may have dampened enthusiasm around Palomar’s longer-term growth trajectory. Palomar Holdings analyst update

Palomar Company Profile

Palomar Holdings, Inc (NASDAQ: PLMR) is a specialty insurance holding company focused on providing medical stop-loss coverage and related administrative services to self-funded employer health plans in the United States. The firm operates through two primary business segments—Medical Stop-Loss and Specialty Program Management—to deliver tailored risk protection and comprehensive program administration.

In its Medical Stop-Loss segment, Palomar underwrites excess and aggregate stop-loss policies designed to shield self-insured employers from catastrophic medical claims that exceed pre-determined retention levels.